Processa Pharmaceuticals, Inc. (PCSA) Press Releases https://www.processapharmaceuticals.com/news-media/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/processapharmaceuticals/files/theme/images/logo-sm.png Processa Pharmaceuticals, Inc. Logo https://www.processapharmaceuticals.com Equisolve Investor Relations Suite <![CDATA[Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference]]> https://www.processapharmaceuticals.com/news-media/press-releases/detail/144/processa-pharmaceuticals-to-attend-44th-annual-j-p-morgan Mon, 12 Jan 26 09:15:00 -0500 https://www.processapharmaceuticals.com/news-media/press-releases/detail/144/processa-pharmaceuticals-to-attend-44th-annual-j-p-morgan <![CDATA[Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study]]> https://www.processapharmaceuticals.com/news-media/press-releases/detail/143/processa-pharmaceuticals-completes-enrollment-of-20th Mon, 05 Jan 26 09:15:00 -0500 https://www.processapharmaceuticals.com/news-media/press-releases/detail/143/processa-pharmaceuticals-completes-enrollment-of-20th <![CDATA[Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer]]> https://www.processapharmaceuticals.com/news-media/press-releases/detail/142/processa-pharmaceuticals-provides-clinical-update-on-phase Wed, 17 Dec 25 08:00:00 -0500 https://www.processapharmaceuticals.com/news-media/press-releases/detail/142/processa-pharmaceuticals-provides-clinical-update-on-phase <![CDATA[Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025]]> https://www.processapharmaceuticals.com/news-media/press-releases/detail/141/processa-pharmaceuticals-announces-poster-presentation-of Wed, 05 Nov 25 09:15:00 -0500 https://www.processapharmaceuticals.com/news-media/press-releases/detail/141/processa-pharmaceuticals-announces-poster-presentation-of <![CDATA[Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies]]> https://www.processapharmaceuticals.com/news-media/press-releases/detail/140/processa-pharmaceuticals-secures-strategic-investment-and Thu, 07 Aug 25 08:30:00 -0400 https://www.processapharmaceuticals.com/news-media/press-releases/detail/140/processa-pharmaceuticals-secures-strategic-investment-and <![CDATA[Processa Pharmaceuticals Provides Portfolio and Business Update]]> https://www.processapharmaceuticals.com/news-media/press-releases/detail/139/processa-pharmaceuticals-provides-portfolio-and-business Tue, 01 Jul 25 09:00:00 -0400 https://www.processapharmaceuticals.com/news-media/press-releases/detail/139/processa-pharmaceuticals-provides-portfolio-and-business <![CDATA[Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering]]> https://www.processapharmaceuticals.com/news-media/press-releases/detail/138/processa-pharmaceuticals-announces-pricing-of-7-million Tue, 17 Jun 25 12:26:00 -0400 https://www.processapharmaceuticals.com/news-media/press-releases/detail/138/processa-pharmaceuticals-announces-pricing-of-7-million <![CDATA[Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate]]> https://www.processapharmaceuticals.com/news-media/press-releases/detail/137/processa-pharmaceuticals-signs-binding-term-sheet-granting Tue, 17 Jun 25 09:00:00 -0400 https://www.processapharmaceuticals.com/news-media/press-releases/detail/137/processa-pharmaceuticals-signs-binding-term-sheet-granting <![CDATA[Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025]]> https://www.processapharmaceuticals.com/news-media/press-releases/detail/136/processa-pharmaceuticals-to-engage-potential-partners-and Fri, 13 Jun 25 08:00:00 -0400 https://www.processapharmaceuticals.com/news-media/press-releases/detail/136/processa-pharmaceuticals-to-engage-potential-partners-and <![CDATA[Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting]]> https://www.processapharmaceuticals.com/news-media/press-releases/detail/135/processa-pharmaceuticals-announces-presentation-and Fri, 30 May 25 09:00:00 -0400 https://www.processapharmaceuticals.com/news-media/press-releases/detail/135/processa-pharmaceuticals-announces-presentation-and